Viewpoint Capital Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-20,416
| Closed | -$228K | – | 141 |
|
|
2024
Q2 | $228K | Buy |
20,416
+5,000
| +32% | +$55.9K | 0.14% | 97 |
|
|
2024
Q1 | $102K | Buy |
15,416
+2,416
| +19% | +$15.9K | 0.06% | 110 |
|
|
2023
Q4 | $58.8K | Hold |
13,000
| – | – | 0.04% | 112 |
|
|
2023
Q3 | $46.5K | Hold |
13,000
| – | – | 0.04% | 108 |
|
|
2023
Q2 | $48K | Hold |
13,000
| – | – | 0.04% | 109 |
|
|
2023
Q1 | $43K | Hold |
13,000
| – | – | 0.04% | 100 |
|
|
2022
Q4 | $50.4K | Buy |
+13,000
| New | +$50.4K | 0.05% | 98 |
|
|
2022
Q3 | – | Sell |
-13,000
| Closed | -$26K | – | 110 |
|
|
2022
Q2 | $26K | Buy |
+13,000
| New | +$26K | 0.02% | 103 |
|